Get started
Author

Kate Gersekowski

ORCID: 0000-0003-4359-3582
Observed ORCID: 0000-0003-4359-3582
OpenAlex ID: A5048829186
Germline BRCA variants, lifestyle and ovarian cancer survival
2022 · Kate Gersekowski, Rachel Delahunty, et al. · Gynecologic Oncology · 11
Risk Factors for Ovarian Cancer by BRCA Status: A Collaborative Case-Only Analysis
2024 · Kate Gersekowski, Renhua Na, et al. · Cancer Epidemiology Biomarkers & Prevention · 8
PDF
Folate Intake and Ovarian Cancer Risk among Women with Endometriosis: A Case–Control Study from the Ovarian Cancer Association Consortium
2023 · Kate Gersekowski, Torukiri I Ibiebele, et al. · Cancer Epidemiology Biomarkers & Prevention · 7
PDF
Green tea consumption, primary treatment outcome and survival after a diagnosis of ovarian cancer
2025 · Kate Gersekowski, Anna DeFazio, et al. · Journal of Epidemiology & Community Health · 1
Using administrative health data to ascertain ovarian cancer treatment information in Australia: a validation against medical records
2026 · Kate Gersekowski, Jim Codde, et al. · Public Health Research & Practice
PDF
Supplementary Figure 2 from Folate Intake and Ovarian Cancer Risk among Women with Endometriosis: A Case–Control Study from the Ovarian Cancer Association Consortium
2025 · Kate Gersekowski, Torukiri I Ibiebele, et al.
PDF
Supplementary Table 1 from Folate Intake and Ovarian Cancer Risk among Women with Endometriosis: A Case–Control Study from the Ovarian Cancer Association Consortium
2025 · Kate Gersekowski, Torukiri I Ibiebele, et al.
PDF
Supplementary Table 5 from Folate Intake and Ovarian Cancer Risk among Women with Endometriosis: A Case–Control Study from the Ovarian Cancer Association Consortium
2025 · Kate Gersekowski, Torukiri I Ibiebele, et al.
PDF
Supplementary Figure 1 from Folate Intake and Ovarian Cancer Risk among Women with Endometriosis: A Case–Control Study from the Ovarian Cancer Association Consortium
2025 · Kate Gersekowski, Torukiri I Ibiebele, et al.
Supplementary Table 2 from Folate Intake and Ovarian Cancer Risk among Women with Endometriosis: A Case–Control Study from the Ovarian Cancer Association Consortium
2025 · Kate Gersekowski, Torukiri I Ibiebele, et al.
PDF
Supplementary Table 3 from Folate Intake and Ovarian Cancer Risk among Women with Endometriosis: A Case–Control Study from the Ovarian Cancer Association Consortium
2025 · Kate Gersekowski, Torukiri I Ibiebele, et al.
PDF
Supplementary Table 4 from Folate Intake and Ovarian Cancer Risk among Women with Endometriosis: A Case–Control Study from the Ovarian Cancer Association Consortium
2025 · Kate Gersekowski, Torukiri I Ibiebele, et al.
PDF
Supplementary Figure 3 from Folate Intake and Ovarian Cancer Risk among Women with Endometriosis: A Case–Control Study from the Ovarian Cancer Association Consortium
2025 · Kate Gersekowski, Torukiri I Ibiebele, et al.
Supplementary Table 3 from Folate intake and ovarian cancer risk among women with endometriosis: a case-control study from the Ovarian Cancer Association Consortium
2024 · Kate Gersekowski, Torukiri I. Ibiebele, et al.
Supplementary Figure 3 from Folate intake and ovarian cancer risk among women with endometriosis: a case-control study from the Ovarian Cancer Association Consortium
2024 · Kate Gersekowski, Torukiri I. Ibiebele, et al.
Supplementary Table 2 from Folate intake and ovarian cancer risk among women with endometriosis: a case-control study from the Ovarian Cancer Association Consortium
2024 · Kate Gersekowski, Torukiri I. Ibiebele, et al.
Supplementary Table 5 from Folate intake and ovarian cancer risk among women with endometriosis: a case-control study from the Ovarian Cancer Association Consortium
2024 · Kate Gersekowski, Torukiri I. Ibiebele, et al.
Supplementary Table 1 from Folate intake and ovarian cancer risk among women with endometriosis: a case-control study from the Ovarian Cancer Association Consortium
2024 · Kate Gersekowski, Torukiri I. Ibiebele, et al.
Supplementary Table 5 from Folate intake and ovarian cancer risk among women with endometriosis: a case-control study from the Ovarian Cancer Association Consortium
2024 · Kate Gersekowski, Torukiri I. Ibiebele, et al.
Supplementary Table 2 from Folate intake and ovarian cancer risk among women with endometriosis: a case-control study from the Ovarian Cancer Association Consortium
2024 · Kate Gersekowski, Torukiri I. Ibiebele, et al.
Supplementary Table 4 from Folate intake and ovarian cancer risk among women with endometriosis: a case-control study from the Ovarian Cancer Association Consortium
2024 · Kate Gersekowski, Torukiri I. Ibiebele, et al.
Supplementary Table 4 from Folate intake and ovarian cancer risk among women with endometriosis: a case-control study from the Ovarian Cancer Association Consortium
2024 · Kate Gersekowski, Torukiri I. Ibiebele, et al.
Supplementary Table 3 from Folate intake and ovarian cancer risk among women with endometriosis: a case-control study from the Ovarian Cancer Association Consortium
2024 · Kate Gersekowski, Torukiri I. Ibiebele, et al.
Supplementary Figure 1 from Folate intake and ovarian cancer risk among women with endometriosis: a case-control study from the Ovarian Cancer Association Consortium
2024 · Kate Gersekowski, Torukiri I. Ibiebele, et al.
Supplementary Figure 2 from Folate intake and ovarian cancer risk among women with endometriosis: a case-control study from the Ovarian Cancer Association Consortium
2024 · Kate Gersekowski, Torukiri I. Ibiebele, et al.
Works count: 82
Citation count: 26
H-index: 3
I10-index: 1
Year
Topic
Type